Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins
Articolo
Data di Pubblicazione:
2019
Citazione:
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins / D. Mangioni, G. Grasselli, C. Abbruzzese, A. Muscatello, A. Gori, A. Bandera. - In: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. - ISSN 1201-9712. - 85(2019 Aug), pp. 70-73. [10.1016/j.ijid.2019.05.022]
Abstract:
Varicella zoster virus (VZV) pneumonia is associated with significant mortality, especially in the immunocompromised host. VZV-specific immunoglobulins (VZIG) are currently used as post-exposure prophylaxis for at-risk patients, but not as adjunctive therapy. A novel case of VZV pneumonia in an immunocompromised patient, treated successfully with intravenous VZIG in combination with acyclovir, is reported here.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Immunocompromised host; Intensive care unit; Intravenous immunoglobulins; Pneumonia; Varicella zoster virus
Elenco autori:
D. Mangioni, G. Grasselli, C. Abbruzzese, A. Muscatello, A. Gori, A. Bandera
Link alla scheda completa: